Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis
Maria‐Gracia Cucurella(Vall d'Hebron Institut de Recerca), J. A. Alonso(Instituto de Ciencia de Materiales de Madrid), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Salvador Pedraza(Hospital Clínic de Barcelona), Àlex Rovira(Centre National de la Recherche Scientifique), Jordi Río(Universitat Autònoma de Barcelona), Maria‐Mar Tintoré(Vall d'Hebron Hospital Universitari)
Cited by 4
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k